XOMA Royalty Corp — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | Sale | 5,000 | $4.33 | $21,650 | 76,939 | Nov 3, 2014 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Sale | 5,000 | $4.57 | $22,850 | 72,021 | Oct 28, 2014 |
| Varian John | CEO | Sale | 10,000 | $3.87 | $38,700 | 325,364 | Oct 15, 2014 |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | Sale | 5,000 | $4.09 | $20,450 | 81,939 | Oct 1, 2014 |
| Neal James R | — | Other | 1,229 | $4.95 | $6,084 | 152,670 | Sep 30, 2014 |
| Varian John | CEO | Option Exercise | 10,000 | $1.24 | $12,400 | 335,364 | Sep 15, 2014 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Option Exercise | 5,000 | $3.04 | $15,200 | 77,021 | Sep 15, 2014 |
| BAKER FELIX | — | Award / Grant | 5,500 | — | — | 2,843,653 | Sep 12, 2014 |
| WYSZOMIERSKI JACK L | — | Award / Grant | 5,500 | — | — | 31,297 | Sep 12, 2014 |
| Walbert Timothy P | — | Award / Grant | 5,500 | — | — | 31,297 | Sep 12, 2014 |
| VAN NESS W DENMAN | — | Award / Grant | 5,500 | — | — | 38,152 | Sep 12, 2014 |
| LIMBER JOSEPH M | — | Award / Grant | 5,500 | — | — | 22,300 | Sep 12, 2014 |
| BOWES WILLIAM K JR | — | Award / Grant | 5,500 | — | — | 32,368 | Sep 12, 2014 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Sale | 10,000 | $4.56 | $45,600 | 72,021 | Sep 4, 2014 |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | Sale | 5,000 | $4.31 | $21,550 | 86,939 | Sep 2, 2014 |
| KURLAND FRED | CFO & VP Finance | Option Exercise | 19,064 | — | — | 81,664 | Aug 15, 2014 |
| Neal James R | VP Business Development | Sale | 6,584 | $4.61 | $30,352 | 144,857 | Aug 15, 2014 |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | Option Exercise | 16,264 | — | — | 97,810 | Aug 15, 2014 |
| Varian John | CEO | Option Exercise | 94,574 | — | — | 380,187 | Aug 15, 2014 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Sale | 10,299 | $4.31 | $44,389 | 88,470 | Aug 14, 2014 |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | Sale | 5,000 | $3.83 | $19,150 | 81,546 | Aug 1, 2014 |
| Varian John | CEO | Option Exercise | 10,000 | $1.24 | $12,400 | 295,613 | Jul 15, 2014 |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | Sale | 5,000 | $4.68 | $23,400 | 86,546 | Jul 1, 2014 |
| Varian John | CEO | Sale | 10,000 | $4.54 | $45,400 | 285,613 | Jun 16, 2014 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Sale | 11,580 | $4.54 | $52,573 | 72,021 | Jun 16, 2014 |
| BOWES WILLIAM K JR | — | Option Exercise | 2,800 | — | — | 26,868 | May 28, 2014 |
| VAN NESS W DENMAN | — | Option Exercise | 3,150 | — | — | 32,652 | May 28, 2014 |
| LIMBER JOSEPH M | — | Option Exercise | 2,800 | — | — | 16,800 | May 28, 2014 |
| Walbert Timothy P | — | Option Exercise | 2,800 | — | — | 25,797 | May 28, 2014 |
| WYSZOMIERSKI JACK L | — | Option Exercise | 2,800 | — | — | 22,997 | May 28, 2014 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Option Exercise | 4,667 | — | — | 85,386 | May 28, 2014 |
| BAKER FELIX | — | Award / Grant | 8,400 | — | — | 2,838,153 | May 22, 2014 |
| LIMBER JOSEPH M | — | Award / Grant | 8,400 | — | — | 14,000 | May 22, 2014 |
| Walbert Timothy P | — | Award / Grant | 8,400 | — | — | 20,197 | May 22, 2014 |
| BOWES WILLIAM K JR | — | Award / Grant | 8,400 | — | — | 21,268 | May 22, 2014 |
| VAN NESS W DENMAN | — | Award / Grant | 9,450 | — | — | 26,352 | May 22, 2014 |
| WYSZOMIERSKI JACK L | — | Award / Grant | 8,400 | — | — | 20,197 | May 22, 2014 |
| Varian John | CEO | Option Exercise | 10,000 | $1.24 | $12,400 | 295,613 | May 15, 2014 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Sale | 10,000 | $3.84 | $38,400 | 80,719 | May 13, 2014 |
| Varian John | CEO | Sale | 10,000 | $4.06 | $40,600 | 285,613 | Apr 15, 2014 |
| KURLAND FRED | CFO & VP Finance | Option Exercise | 10,875 | — | — | 68,515 | Mar 18, 2014 |
| Varian John | CEO | Option Exercise | 36,907 | — | — | 306,942 | Mar 18, 2014 |
| Neal James R | VP Business Development | Sale | 2,671 | $6.32 | $16,881 | 151,441 | Mar 18, 2014 |
| Klein Thomas | Chief Commercial Officer | Option Exercise | 667 | — | — | 44,115 | Mar 18, 2014 |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | Sale | 3,419 | $6.32 | $21,608 | 91,546 | Mar 18, 2014 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Option Exercise | 18,205 | — | — | 97,707 | Mar 18, 2014 |
| Varian John | CEO | Option Exercise | 10,000 | $1.24 | $12,400 | 280,035 | Mar 17, 2014 |
| LIMBER JOSEPH M | — | Option Exercise | 5,600 | — | — | 5,600 | Mar 10, 2014 |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | Award / Grant | 43,448 | — | — | 85,465 | Feb 27, 2014 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Award / Grant | 68,793 | — | — | 72,021 | Feb 27, 2014 |